Platelet-activating factor enhances complement-dependent phagocytosis of diamide-treated erythrocytes by human monocytes through activation of protein kinase C and phosphorylation of complement receptor type one (CR1)

J Biol Chem. 1989 Dec 25;264(36):21711-9.

Abstract

Oligomerization of band 3 protein has been recently indicated as an early event in senescent or damaged red cell membrane followed by specific deposition of anti-band 3 antibodies and binding of complement C3 fragments. The band 3-anti-band 3-C3b complex is recognized by homologous monocytes, and phagocytosis ensues. This study shows that recognition of the anti-band 3-C3b complex by the monocyte C3b receptor type one (CR1) plays a crucial role in the process of removal of damaged red cells. Indeed, blocking of monocyte CR1 with an anti-CR1 monoclonal antibody abrogated phagocytosis of diamide-treated red cells. Platelet-activating factor (PAF) is a phospholipid mediator involved in inflammatory processes. Nanomolar (R)-PAF enhanced the CR1-dependent phagocytosis of diamide-treated human red cell and of sheep red cells coated with C3b, induced the fast translocation of protein kinase C to monocyte membrane compartment, and stimulated the phosphorylation of monocyte CR1. The biologically inert lyso-PAF and the enantiomer (S)-PAF were inactive. PAF receptor antagonists and inhibitors of protein kinase C blocked the enhancement of phagocytosis induced by PAF. Protein kinase C translocation, phosphorylation of CR1, and stimulation of this receptor to an active state capable of mediating phagocytosis represent a novel pathway by which PAF interferes with red cell homeostasis and possibly modulates inflammatory reactions and host mechanisms against infections.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine
  • Alkaloids / pharmacology
  • Azo Compounds / pharmacology*
  • Cell Adhesion
  • Complement System Proteins / physiology*
  • Diamide / pharmacology*
  • Enzyme Activation
  • Erythrocytes / drug effects
  • Erythrocytes / physiology*
  • Humans
  • In Vitro Techniques
  • Isoquinolines / pharmacology
  • Kinetics
  • Monocytes / drug effects
  • Monocytes / enzymology
  • Monocytes / physiology*
  • Palmitoylcarnitine / pharmacology
  • Phagocytosis / drug effects*
  • Phosphorylation
  • Piperazines / pharmacology
  • Platelet Activating Factor / pharmacology*
  • Protein Kinase C / antagonists & inhibitors
  • Protein Kinase C / blood*
  • Receptors, Complement / metabolism*
  • Sphingosine / pharmacology
  • Staurosporine
  • Structure-Activity Relationship

Substances

  • Alkaloids
  • Azo Compounds
  • Isoquinolines
  • Piperazines
  • Platelet Activating Factor
  • Receptors, Complement
  • Diamide
  • Palmitoylcarnitine
  • 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine
  • Complement System Proteins
  • Protein Kinase C
  • Staurosporine
  • Sphingosine